Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hou

Showing results (421-430 of 454) with videos related to

Pageof 46
Sort By:
Cancer Chemotherapy and Pharmacology|January 9, 2015
A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridineEdward M Newman, Robert J Morgan, Shivaani Kummar, et al.
Gene Therapy|May 5, 2006
Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinomaR Zhang, L Tian, L-J Chen, et al.
Central European Journal of Urology|February 5, 2020
Robotic ileal interposition for long ureteric strictureChi Hang Yee, David K W Leung, Peter K F Chiu, et al.
Mutation Research|January 15, 2000
Validation of the human T-lymphocyte cloning assay--ring test report from the EU concerted action on HPRT mutation (EUCAHM)S M Hou, F J Van Dam, F de Zwart, et al.
European Review for Medical and Pharmacological Sciences|April 10, 2015
Efficacy of drug-eluting stent for chronic total coronary occlusions at different follow-up duration: a systematic review and meta-analysisS-S Yang, L Tang, G-G Ge, et al.
Zhonghua Yi Xue Za Zhi|September 20, 2023
[The consistency of skeletal muscle mass measured by CT at L<sub>1</sub> and L<sub>3</sub> levels and the correlation of skeletal muscle density at L<sub>1</sub> level with prognosis in dialysis patients]M Yang, S M Hou, L Yuan, et al.
The Review of Scientific Instruments|December 3, 2016
Measurement of the deuterium Balmer series line emission on EASTC R Wu, J Huang, W Gao, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 3, 2017
Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancerW-K Yap, Y-C Chang, C-K Tseng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2015
Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradationS Fu, M M Hou, A Naing, et al.
Mucosal Immunology|March 5, 2015
Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axisC Ning, Y-Y Li, Y Wang, et al.
Pageof 46

Showing results (421-430 of 454) with videos related to

Sort By:
Pageof 46
Cancer Chemotherapy and Pharmacology|January 9, 2015
A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridineEdward M Newman, Robert J Morgan, Shivaani Kummar, et al.
Gene Therapy|May 5, 2006
Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinomaR Zhang, L Tian, L-J Chen, et al.
Central European Journal of Urology|February 5, 2020
Robotic ileal interposition for long ureteric strictureChi Hang Yee, David K W Leung, Peter K F Chiu, et al.
Mutation Research|January 15, 2000
Validation of the human T-lymphocyte cloning assay--ring test report from the EU concerted action on HPRT mutation (EUCAHM)S M Hou, F J Van Dam, F de Zwart, et al.
European Review for Medical and Pharmacological Sciences|April 10, 2015
Efficacy of drug-eluting stent for chronic total coronary occlusions at different follow-up duration: a systematic review and meta-analysisS-S Yang, L Tang, G-G Ge, et al.
Zhonghua Yi Xue Za Zhi|September 20, 2023
[The consistency of skeletal muscle mass measured by CT at L<sub>1</sub> and L<sub>3</sub> levels and the correlation of skeletal muscle density at L<sub>1</sub> level with prognosis in dialysis patients]M Yang, S M Hou, L Yuan, et al.
The Review of Scientific Instruments|December 3, 2016
Measurement of the deuterium Balmer series line emission on EASTC R Wu, J Huang, W Gao, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 3, 2017
Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancerW-K Yap, Y-C Chang, C-K Tseng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2015
Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradationS Fu, M M Hou, A Naing, et al.
Mucosal Immunology|March 5, 2015
Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axisC Ning, Y-Y Li, Y Wang, et al.
Pageof 46